Clinical trial Recruiting at 1 site Interventional

Buccal fat pad versus platelet-rich fibrin to cover zygomatic implants

Official title: Assessment of Soft Tissue Thickness Following Utilization of Buccal Pad of Fat Versus Platelet-rich Fibrin for Covering Zygomatic Implants: A Randomized Clinical Trial

Run by Cairo University · NCT07562334 · Data updated 2026-11-12

We will test whether using the buccal fat pad or platelet-rich fibrin to cover zygomatic implants leads to thicker gum tissue and fewer complications for people with severely atrophic upper jaws receiving zygomatic implants.

More Soft Tissue Augmentation at Dental Implants trials

Quick facts

Study typeInterventional
SexAll
Enrollment24 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Cairo Governorate)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedFebruary 1, 2027
Study endsMay 1, 2027
Registry record updatedMay 1, 2026
Trial IDNCT07562334 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are motivated adults with severely atrophic edentulous upper jaws (Cawood IV–VI), adequate anterior bone for two conventional implants (8–12 mm), lacking posterior maxillary support, and in good systemic health (ASA I–II).

Probably not a fit

Patients with uncontrolled systemic disease (including uncontrolled diabetes or current bisphosphonate therapy), heavy smokers (>20 cigarettes/day), acute sinusitis, severe bruxism or other parafunctional habits, psychiatric problems, or malignancy/pathology of the maxilla or zygoma are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized clinical trial will compare two soft-tissue coverage techniques—buccal fat pad (BFP) and platelet-rich fibrin (PRF)—used to cover the body of zygomatic implants placed for reconstruction of a severely atrophic posterior maxilla. Eligible patients with Cawood class IV–VI edentulous upper arches and sufficient anterior bone for two conventional implants will be randomized to receive either BFP or PRF coverage at a single center. Primary outcomes include peri-implant soft tissue thickness, rates of mucosal dehiscence, and other postoperative complications measured through the immediate loading phase and up to final restoration. The trial aims to identify which coverage method provides a more stable soft tissue profile with fewer complications.

Why it matters

Potential benefit: If successful, the preferred coverage method could reduce mucosal dehiscence and postoperative complications and improve soft-tissue thickness around zygomatic implants, facilitating immediate loading and final restoration.

How similar studies have gone: Both buccal fat pad and platelet-rich fibrin have been reported to improve soft tissue closure in small series, but direct randomized comparisons specifically for zygomatic implant coverage are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with severely atrophic edentulous upper arch (Cawood class IV, V, VI) that could not be restored by other type of treatment
2. Patients who had at least 8-12 mm vertical bone height in anterior maxilla to allow installation of 2 conventional implants.
3. Lacking posterior maxillary bone support due to significant sinus pneumatization
4. Good systemic health (ASA score I-II)
5. Highly motivated patients

Exclusion Criteria:

1. Patient not willing to give his/her informed consent.
2. Patients with systemic disease that did not permit the surgical procedure (including general anesthesia).
3. Patients with uncontrolled diabetes or under bisphosphonate therapy.
4. Heavy smoker. (\> 20 cigarettes daily)
5. Patient with psychiatric problems, severe bruxism or other parafunctional habits.
6. Acute sinusitis.
7. Malignancy or pathology in Maxilla or Zygoma.

Where it's running

  • Cairo university, Faculty of dentistry
    Cairo, Cairo Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.